Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

COMBIVENT

ALBUTEROL SULFATE; IPRATROPIUM BROMIDE

Standard Dose
EQ 0.09MG BASE/INH;0.018MG/INH
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Discontinued
Summary

Approval overview COMBIVENT is listed in Drugs@FDA under application 020291 (NDA).

Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ALBUTEROL SULFATE; IPRATROPIUM BROMIDE Form and strength AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH;0.018MG/INH Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2012-09-17 00:00:00.

Structured Monograph

Clinical summary

Approval overview COMBIVENT is listed in Drugs@FDA under application 020291 (NDA). Review priority: UNKNOWN Marketing status: Discontinued Active ingredient ALBUTEROL SULFATE; IPRATROPIUM BROMIDE Form and strength AEROSOL, METERED;INHALATION - EQ 0.09MG BASE/INH;0.018MG/INH Sponsor BOEHRINGER INGELHEIM Submission history Latest submission status date: 2012-09-17 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.